期刊文献+

人正、反义转化生长因子beta1基因真核表达载体的构建 被引量:1

Construction of sense and antisense expression vector for human transforming growth factor-beta 1
下载PDF
导出
摘要 目的 :构建人转化生长因子beta 1(TGFβ1)正、反义基因真核表达载体。方法 :从人胎脑的cDNA文库中扩增出TGFβ1共 12 84bp长的DNA片段后 ,与T载体直接进行高效连接 ,并测序证实无突变。接着利用TGFβ1引物两端所设计的酶切位点将目的片段定向亚克隆到真核表达载体pcDNA3.1( )。构建的正反义表达重组体 (pcDNA3.1 TGFβ1和pcDNA3.1 antiTGFβ1)经限制性内切酶消化证实其中有目的片段完整插入。结果 :本实验成功构建了人正、反义TGFβ1基因真核表达载体。结论 :人正、反义TGFβ1基因真核表达载体的构建 ,为今后研究腹膜纤维化的防治奠定了实验基础。 Objective To construct transforming growth factor beta 1 ( TGFβ1) sense and antisense eukaryotic expression vector. Methods The TGFβ1 cDNA fragments with 1 284 base pairs were obtained by PCR from human fetal brain cDNA. The efficient link was carried out directly between the TGFβ1 cDNA and the vector using PGEM T vector system,which was confirmed by DNA sequencing. Then the target fragment was subcloned into eukaryotic expression vector pcDNA3.1( ) in orientation.The forward and reverse inserting recombinants were confirmed by restriction endonuclease digestion ( EcoR Ⅰand Hind Ⅲ).Results Recombinant human TGFβ1 sense and antisense expression vectors were constructed successfully.Conclusion The human TGFβ1 sense and antisense expression vectors may be the experimental basis of peritoneal fibrosis study.
出处 《湖南医科大学学报》 CSCD 北大核心 2003年第5期451-454,共4页 Bulletin of Hunan Medical University
基金 教育部高等学校重点实验室访问学者基金 (教技司 2 0 0 0170 ) 湖南省自然科学基金项目( 0 1JJY 2 0 71)
关键词 转化生长因子Β RNA 反义 基因疗法 transforming growth factor β RNA, antisense gene therapy
  • 相关文献

参考文献16

  • 1Border WA Ruoslahti E.Transforming growth factor-β in disease:the dark side of tissue repair[J].J Clin Invest,1992,90(1):1-7.
  • 2萨姆布鲁克J 弗里奇E.F 曼尼阿蒂斯T.分子克隆实验指南:第2版[M].北京: 科学出版社,2002.34-69.
  • 3Border WA Noble NA.TGF-β in kidney fibrosis:A target for gene therapy[J].Kidney Int,1997,51(5):1388-1396.
  • 4Kang DH, Hong YS, Lim HJ,et al. High glucose solution and spent dialysate stimulale the synthesis of transforming growth factor-β1 of human peritoneal mesothelial cells: effect of eytokine costimulation [ J ]. Petit Dial Int, 1999,19 ( 3 ) :221-230.
  • 5Yang WS, Kim BS, Lee SK,et al. Interleukin-1β stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells[J]. Perit Dial Int,1999,19(3) : 211-220.
  • 6Mlambo NC, Hylander B, Brauner A, et al. Increased levels of transforming growth factor-β1 and basic fibroblast growth factor in patients on CAPD : a study during non-infected steady state and peritonitis[J]. Irflammation,1999,23(2) :131-139.
  • 7Margetts PJ, Kolb M, Gah T, et al. Gene transfer of tansforming growth factor-beta 1 to the rat peritoneum:effect on membrane function[J]. J Am Soc Nephrol.2001,12(10) :2029-2039.
  • 8Border WA, Noble NA. TGF-13 in kidney fibrosis:A target for gene therapy [ J ]. Kidney Int, 1997,51 ( 5 ) : 1388-1396.
  • 9Peters H, Border WA, Noble NA. Targeting TGFβ1 overexpression in renal disease: Maximizing the antifibrotic action of angiotension Ⅱ blockade[ J ]. Kidney Int, 1998,54 ( 5 ) : 1570-1580.
  • 10Border WA, Ruodahti E. Transforming growth factor-β in disease:the dark side of tissue repair[J]. J Clin Invest, 1992,90 ( 1 ) :1-7.

共引文献5

同被引文献11

  • 1[1]Border WA, Noble NA. TGFβ in kidney fibrosis: A target for gene therapy [J]. Kidney Int, 1997, 51(5): 1388-1396.
  • 2[3]Gunal AI, Duman S, Sen S,et al. By reducing TGFβ, octreotide lessens the peritoneal derangements induced by a high glucose solution [J].J Nephrol, 2001,14(3):184-189.
  • 3[6]Topley N. The cytokine network controlling peritoneal inflammation [J]. Perit Dial Int, 1995, 15(suppl):35-40.
  • 4[7]Kang DH, Hong YS, Lim HJ,et al. High glucose solution and spent dialysate stimulate the synthesis of transfraing growth factor β of human peritoneal mesothelial cells: effect of cytokine costimulation [J]. Perit Dial Int, 1999, 19(3): 221-230.
  • 5[8]Yang WS, Kim BS, Lee SK, et al. Interleukin-1β stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells [J]. Perit Dial Int,1999,19(3):211-220.
  • 6[9]Mlambo NC,Hylander B, Brauner A.Increased levels of transforming growth factor-β1 and basic fibroblast growth factor in patients on CAPD:a study during non-infected steady state and peritonitis inflammation [J]. 1999,23(2):131-139.
  • 7[10]Margetts PJ, Kolb M, Galt T, et al. Gene transfer of transforming growth factor-betal to the rat peritoneum: effect on membrane function [J]. J Am Soc Nephrol, 2001, 12(10): 2029-2039.
  • 8[11]Border WA, Noble NA. TGFβ in kidney fibrosis: A target for gene therapy [J]. Kidney Int,1997,51(5):1388-1396.
  • 9[12]Peters SH, Border WA, Noble NA. Over expression in renal disease: Maximizing the antifibrotic action of angiotension Ⅱ blockade [J]. Kidney Int, 1998, 54(5): 1570-1580.
  • 10刘伏友,段绍斌,龙志高,肖平,陈星,潘乾,罗季安,彭佑铭.人腹膜间皮细胞的培养及特征[J].湖南医科大学学报,2001,26(4):321-324. 被引量:23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部